The Envelope protein (E) is one of the four structural proteins encoded by the genome of SARS-CoV and SARS-CoV-2 Coronaviruses. It is an integral membrane protein, highly expressed in the host cell, which is known to have an important role in Coronaviruses maturation, assembly and virulence. The E protein presents a PDZ-binding motif at its C-terminus. One of the key interactors of the E protein in the intracellular environment is the PDZ containing protein PALS1. This interaction is known to play a key role in the SARS-CoV pathology and suspected to affect the integrity of the lung epithelia. In this paper we measured and compared the affinity of peptides mimicking the E protein from SARS-CoV and SARS-CoV-2 for the PDZ domain of PALS1, through equilibrium and kinetic binding experiments. Our results support the hypothesis that the increased virulence of SARS-CoV-2 compared to SARS-CoV may rely on the increased affinity of its Envelope protein for PALS1.
Reactive oxygen species (ROS) are produced predominantly by the mitochondrial electron transport chain and by NADPH oxidases in peroxisomes and in the endoplasmic reticulum. The antioxidative defense counters overproduction of ROS with detoxifying enzymes and molecular scavengers, for instance, superoxide dismutase and glutathione, in order to restore redox homeostasis. Mutations in the redox landscape can induce carcinogenesis, whereas increased ROS production can perpetuate cancer development. Moreover, cancer cells can increase production of antioxidants, leading to resistance against chemo- or radiotherapy. Research has been developing pharmaceuticals to target the redox landscape in cancer. For instance, inhibition of key players in the redox landscape aims to modulate ROS production in order to prevent tumor development or to sensitize cancer cells in radiotherapy. Besides the redox landscape of a single cell, alternative strategies take aim at the multi-cellular level. Extracellular vesicles, such as exosomes, are crucial for the development of the hypoxic tumor microenvironment, and hence are explored as target and as drug delivery systems in cancer therapy. This review summarizes the current pharmaceutical and experimental interventions of the cancer redox landscape.
The complex between the N-methyl-d-aspartate
receptor (NMDAR), neuronal nitric oxide synthase (nNOS), and the postsynaptic
density protein-95 (PSD-95) is an attractive therapeutic target for
the treatment of acute ischemic stroke. The complex is formed via
the PDZ protein domains of PSD-95, and efforts to disrupt the complex
have generally been based on C-terminal peptides derived from the
NMDAR. However, nNOS binds PSD-95 through a β-hairpin motif,
providing an alternative starting point for developing PSD-95 inhibitors.
Here, we designed a cyclic nNOS β-hairpin mimetic peptide and
generated cyclic nNOS β-hairpin peptide arrays with natural
and unnatural amino acids (AAs), which provided molecular insights
into this interaction. We then optimized cyclic peptides and identified
a potent inhibitor of the nNOS/PSD-95 interaction, with the highest
affinity reported thus far for a peptide macrocycle inhibitor of PDZ
domains, which serves as a template for the development of treatment
for acute ischemic stroke.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.